NCT07107841Recruiting
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for the Treatment of Androgenic Alopecia (Single Site)
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Acorn Biolabs Inc.
- Participants (registry)
- 60
- Start
- October 2025
- Primary completion
- September 2027 (planned)
- Study completion
- September 2027 (planned)
- Last registry update
- February 2026
- Countries
- United States
Conditions studied: Androgenic Alopecia, Alopecia, Baldness
Interventions: Autologous Hair Follicle-Derived Secretome, aHFS, Placebo Control
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.